US equities |
MU $928.76 ▲+0.00% SNDK $1,304.84 ▲+0.00% SKHY $145.36 ▲+0.00% TSLA $407.46 ▲+0.00% NVDA $217.94 ▲+0.00% GOOGL $320.58 ▲+0.00% SPCX $148.58 ▲+0.00% INTC $93.74 ▲+0.00%
FinancialContent

Latest News about Adrian Rawcliffe

Recent news which mentions Adrian Rawcliffe

Adaptimmune to acquire Boston-area cell therapy company TCR² Therapeutics
Tags Tcr2 Therapeutics Inc/ (no revenue) Mergers and Acquisitions TCR2 Therapeutics Inc/
From Business Journals
Lab notes: Adaptimmune to reduce workforce; NRx completes $11M debt financing
Tickers INNO
Tags Nabriva Therapeutics plc Ireland GlaxoSmithKline PLC Biotech
From Business Journals